Stock ALVO ALVOTECH
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Alvotech

Equities

ALVO

LU2458332611

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
13.35 USD 0.00% Intraday chart for Alvotech -0.15% +16.29%
Apr. 30 Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals MT
Apr. 30 Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Le ultime operazioni dei gestori star
Die jüngsten Transaktionen der Star-Fondsmanager
De recentste transacties van de sterbeheerders
Las últimas operaciones de los gestores estrella
Les dernières transactions des gérants stars
Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals
Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent
Alvotech Announces U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Alvotech’s Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study
Alvotech Announces Topline Results from A Confirmatory Clinical Study for AVT05, A Proposed Biosimilar for Simponi
Alvotech Signs U.S. Agreement to Expand Access for Newly Approved High-Concentration Interchangeable Biosimilar to Humira®
Alvotech and Teva Announces U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara (ustekinumab)
J&J beats first-quarter profit estimates on cancer drugs strength
Alvotech Provides Earnings Guidance for the Year 2024 and 2025
Alvotech Full-Year 2023 Loss Narrows, Revenue Rises
Alvotech Reports Earnings Results for the Full Year Ended December 31, 2023
Alvotech Announces Executive Changes
Sector Update: Health Care Stocks Mixed Premarket Monday
Alvotech, Teva Say Simlandi Receives US FDA Approval as Interchangeable Humira Biosimilar
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALVO Stock
  4. News Alvotech
  5. Other languages
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW